year,stock,source,target,sublist.holder,sublist.location,sublist.is_coreSource,sublist.table_source1,sublist.table_source2,sublist.table_source3,sublist.table_source4,market,group,taxcode.source,taxcode.target,china.note,X1,修正,非集團
2016,6540,喜康壽生物醫藥(香港)有限公司,健赫力(武漢)生物醫藥有限公司,0.4,china,0,1,0,1,0,興櫃,G6540,NA,NA,NA,NA,NA,NA
2016,6540,喜康壽生物醫藥(香港)有限公司,喜康(武漢)生物醫藥有限公司,1,china,0,1,0,1,0,興櫃,G6540,NA,NA,NA,NA,NA,NA
2016,6540,"Sequoia Capital CV IV Holdco.,",喜康(開曼)控股股份有限公司,NA,NA,0,0,0,0,1,興櫃,G6540,NA,NA,NA,NA,NA,NA
2016,6540,"Biomark Capital Fund IV, L.P.",喜康(開曼)控股股份有限公司,NA,NA,0,0,0,0,1,興櫃,G6540,NA,NA,NA,NA,NA,NA
2016,6540,Milestone Biopharma I Limited,喜康(開曼)控股股份有限公司,NA,NA,0,0,0,0,1,興櫃,G6540,NA,NA,NA,NA,NA,NA
2016,6540,喜康(開曼)控股股份有限公司,喜康生技股份有限公司,1,台灣,1,1,0,0,0,興櫃,G6540,NA,54151980,NA,NA,NA,NA
2016,6540,喜康(開曼)控股股份有限公司,喜康壽生物醫藥(香港)有限公司,1,香港,1,1,0,0,0,興櫃,G6540,NA,NA,NA,NA,NA,NA
